vs

Side-by-side financial comparison of GLACIER BANCORP, INC. (GBCI) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

GLACIER BANCORP, INC. is the larger business by last-quarter revenue ($306.8M vs $197.9M, roughly 1.5× REPLIGEN CORP). GLACIER BANCORP, INC. runs the higher net margin — 26.8% vs 6.7%, a 20.1% gap on every dollar of revenue. Over the past eight quarters, GLACIER BANCORP, INC.'s revenue compounded faster (24.3% CAGR vs 14.4%).

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

GBCI vs RGEN — Head-to-Head

Bigger by revenue
GBCI
GBCI
1.5× larger
GBCI
$306.8M
$197.9M
RGEN
Higher net margin
GBCI
GBCI
20.1% more per $
GBCI
26.8%
6.7%
RGEN
Faster 2-yr revenue CAGR
GBCI
GBCI
Annualised
GBCI
24.3%
14.4%
RGEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GBCI
GBCI
RGEN
RGEN
Revenue
$306.8M
$197.9M
Net Profit
$82.1M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
26.8%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.63
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GBCI
GBCI
RGEN
RGEN
Q1 26
$306.8M
Q4 25
$306.5M
$197.9M
Q3 25
$260.7M
$188.8M
Q2 25
$240.6M
$182.4M
Q1 25
$222.6M
$169.2M
Q4 24
$223.0M
$174.1M
Q3 24
$214.9M
$154.9M
Q2 24
$198.7M
$154.1M
Net Profit
GBCI
GBCI
RGEN
RGEN
Q1 26
$82.1M
Q4 25
$63.8M
$13.3M
Q3 25
$67.9M
$14.9M
Q2 25
$52.8M
$14.9M
Q1 25
$54.6M
$5.8M
Q4 24
$61.8M
$-30.3M
Q3 24
$51.1M
$-654.0K
Q2 24
$44.7M
$3.3M
Gross Margin
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
24.9%
9.0%
Q3 25
32.7%
8.9%
Q2 25
27.1%
7.6%
Q1 25
28.5%
3.9%
Q4 24
33.0%
-17.7%
Q3 24
28.9%
-5.1%
Q2 24
27.3%
1.0%
Net Margin
GBCI
GBCI
RGEN
RGEN
Q1 26
26.8%
Q4 25
20.8%
6.7%
Q3 25
26.0%
7.9%
Q2 25
21.9%
8.2%
Q1 25
24.5%
3.4%
Q4 24
27.7%
-17.4%
Q3 24
23.8%
-0.4%
Q2 24
22.5%
2.2%
EPS (diluted)
GBCI
GBCI
RGEN
RGEN
Q1 26
$0.63
Q4 25
$0.49
$0.24
Q3 25
$0.57
$0.26
Q2 25
$0.45
$0.26
Q1 25
$0.48
$0.10
Q4 24
$0.55
$-0.55
Q3 24
$0.45
$-0.01
Q2 24
$0.39
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GBCI
GBCI
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$1.4B
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$4.2B
$2.1B
Total Assets
$31.7B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GBCI
GBCI
RGEN
RGEN
Q1 26
$1.4B
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
GBCI
GBCI
RGEN
RGEN
Q1 26
$4.2B
Q4 25
$4.2B
$2.1B
Q3 25
$3.6B
$2.1B
Q2 25
$3.5B
$2.1B
Q1 25
$3.3B
$2.0B
Q4 24
$3.2B
$2.0B
Q3 24
$3.2B
$2.0B
Q2 24
$3.1B
$2.0B
Total Assets
GBCI
GBCI
RGEN
RGEN
Q1 26
$31.7B
Q4 25
$32.0B
$2.9B
Q3 25
$29.0B
$2.9B
Q2 25
$29.0B
$2.9B
Q1 25
$27.9B
$2.9B
Q4 24
$27.9B
$2.8B
Q3 24
$28.2B
$2.8B
Q2 24
$27.8B
$2.9B
Debt / Equity
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GBCI
GBCI
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
$374.4M
$25.7M
Q3 25
$112.4M
$48.1M
Q2 25
$86.0M
$28.6M
Q1 25
$52.4M
$15.0M
Q4 24
$258.0M
$39.2M
Q3 24
$150.1M
$49.3M
Q2 24
$62.7M
$42.2M
Free Cash Flow
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
$347.6M
$17.6M
Q3 25
$104.8M
$43.4M
Q2 25
$79.5M
$21.5M
Q1 25
$46.8M
$11.4M
Q4 24
$209.8M
$33.6M
Q3 24
$137.7M
$42.3M
Q2 24
$44.1M
$37.4M
FCF Margin
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
113.4%
8.9%
Q3 25
40.2%
23.0%
Q2 25
33.1%
11.8%
Q1 25
21.0%
6.8%
Q4 24
94.1%
19.3%
Q3 24
64.1%
27.3%
Q2 24
22.2%
24.3%
Capex Intensity
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
8.8%
4.1%
Q3 25
2.9%
2.5%
Q2 25
2.7%
3.9%
Q1 25
2.5%
2.1%
Q4 24
21.6%
3.2%
Q3 24
5.8%
4.5%
Q2 24
9.3%
3.1%
Cash Conversion
GBCI
GBCI
RGEN
RGEN
Q1 26
Q4 25
5.87×
1.93×
Q3 25
1.66×
3.23×
Q2 25
1.63×
1.92×
Q1 25
0.96×
2.57×
Q4 24
4.18×
Q3 24
2.94×
Q2 24
1.40×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GBCI
GBCI

Net Interest Income$268.7M88%
Noninterest Income$38.1M12%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons